We are live on ! Find out more
EOLS icon

Evolus

164 hedge funds and large institutions have $573M invested in Evolus in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,044% more call options, than puts

Call options by funds: $972K | Put options by funds: $85K

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

12% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 49

2.28% more ownership

Funds ownership: 79.72%82% (+2.3%)

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

1% less funds holding

Funds holding: 165164 (-1)

30% less capital invested

Capital invested by funds: $815M → $573M (-$241M)

Holders
164
Holders Change
-1
Holders Change %
-0.61%
% of All Funds
2.16%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.09%
New
26
Increased
55
Reduced
49
Closed
25
Calls
$972K
Puts
$85K
Net Calls
+$887K
Net Calls Change
-$813K
Name Holding Trade Value Shares
Change
Change in
Stake
First Manhattan
76
First Manhattan
New York
$442K
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
$400K -$373K -26,535 -42%
SSA
78
Schonfeld Strategic Advisors
New York
$383K +$188K +13,363 +63%
MIM
79
MetLife Investment Management
New Jersey
$378K +$28.7K +2,044 +6%
Two Sigma Investments
80
Two Sigma Investments
New York
$375K -$254K -18,055 -35%
Principal Financial Group
81
Principal Financial Group
Iowa
$368K +$42K +2,989 +10%
Mirae Asset Global ETFs Holdings
82
Mirae Asset Global ETFs Holdings
Hong Kong
$347K +$15.4K +1,094 +4%
Allianz Asset Management
83
Allianz Asset Management
Germany
$323K -$307K -21,800 -43%
Comerica Bank
84
Comerica Bank
Texas
$312K +$398K +28,301 New
CF
85
Corebridge Financial
Texas
$303K -$29.2K -2,075 -7%
SG Americas Securities
86
SG Americas Securities
New York
$300K -$159K -11,274 -29%
Squarepoint
87
Squarepoint
New York
$289K -$902K -64,180 -71%
BRA
88
Bender Robert & Associates
California
$277K +$353K +25,070 New
AG
89
Algert Global
California
$269K -$2.57K -183 -0.7%
EGM
90
Engineers Gate Manager
New York
$267K +$340K +24,206 New
PAP
91
Persistent Asset Partners
Hong Kong
$266K +$268K +19,054 New
HF
92
HRT Financial
New York
$259K -$183K -13,006 -36%
TRCT
93
Tower Research Capital (TRC)
New York
$237K +$253K +17,993 +514%
LPL Financial
94
LPL Financial
California
$233K
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$228K -$7.04K -501 -2%
DTL
96
Dynamic Technology Lab
Singapore
$208K +$99.9K +7,103 +60%
IIM
97
INTECH Investment Management
Florida
$206K +$64.9K +4,613 +33%
ProShare Advisors
98
ProShare Advisors
Maryland
$205K +$61.8K +4,392 +31%
Invesco
99
Invesco
Georgia
$202K -$1.17M -83,072 -82%
Janus Henderson Group
100
Janus Henderson Group
United Kingdom
$195K

EOLS Hedge Fund Activity: Q4 2024 in Review

164 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q4 2024, worth a combined $573M — down 30% from $815M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new EOLS positions and 25 closed out — a net gain of 1 holder — while 55 added to existing stakes and 49 trimmed.

The largest buyer was Tri Locum Partners, opening a new position worth an estimated $10.4M. The largest seller was Assenagon Asset Management, cutting an estimated $7.31M.

  • 164 institutional investors held Evolus (EOLS) as of Q4 2024, down from 165 in Q3 2024.
  • Funds reported $573M of Evolus stock for Q4 2024, down 30% quarter-over-quarter.
  • 26 funds opened new Evolus positions in Q4 2024 and 25 closed out, a net change of +1 holder.
  • The largest Evolus buyer in Q4 2024 was Tri Locum Partners, an estimated $10.4M added.
  • The largest Evolus seller in Q4 2024 was Assenagon Asset Management, an estimated $7.31M sold.

Based on aggregated 13F filings for Q4 2024.